Protagonist Therapeutics Reports Q2 2026 Financial Results

What Happened
Protagonist Therapeutics, Inc. announced its financial results for the quarter ended June 30, 2026 in a press release dated August 5, 2026. The company furnished the press release as Exhibit 99.1 to an 8-K (Item 2.02) and also made an updated corporate presentation available on its website, furnished as Exhibit 99.2 (Item 7.01).

Key Details

• Report date: August 5, 2026; quarter covered: ended June 30, 2026.
• Press release titled “Protagonist Reports Second Quarter 2026 Financial Results and Provides Corporate Update” is furnished as Exhibit 99.1.
• Updated corporate presentation dated August 5, 2026 is furnished as Exhibit 99.2 and posted on the company website.
• The filing notes the furnished exhibits are not “filed” for purposes of Section 18 of the Exchange Act and are not subject to certain liabilities under the Securities Act.

Why It Matters
This 8-K is a routine earnings disclosure that gives investors the company’s latest quarterly results and any accompanying corporate updates via the presentation. Retail investors should review the press release and presentation (available on the company website or in the 8-K exhibits) for revenue, profit/loss, guidance, or operational updates that could affect the company’s outlook and share price.